WHO Antenatal Care Guideline Implementation Guide
0.3.0 - CI Build International flag

WHO Antenatal Care Guideline Implementation Guide, published by World Health Organization (WHO). This guide is not an authorized publication; it is the continuous build for version 0.3.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/WorldHealthOrganization/smart-anc/ and changes regularly. See the Directory of published versions

PlanDefinition: ANC.DT.22 Asymptomatic bacteriuria (ASB) diagnosis

Official URL: http://fhir.org/guides/who/anc-cds/PlanDefinition/ANCDT22 Version: 0.3.0
Active as of 2021-06-11 Computable Name: ANCDT22
Other Identifiers: ANC.DT.22 (use: official)

Usage:Workflow Task: Diagnosis and treatment

If the woman tests positive for ASB, provide counselling and treatment as needed.

Id: ANCDT22
Url: ANC.DT.22 Asymptomatic bacteriuria (ASB) diagnosis
Version: 0.3.0
Identifier:

value: ANC.DT.22

Name: ANCDT22
Title: ANC.DT.22 Asymptomatic bacteriuria (ASB) diagnosis
Status: active
Experimental: false
Type:

system: PlanDefinitionType

code: eca-rule

Date: 2021-06-11 23:25:04-0600
Publisher: World Health Organization (WHO)
Description: If the woman tests positive for ASB, provide counselling and treatment as needed.
Use Context:
codevaluedisplay
task ANC.B10.4 Diagnosis and treatment
Jurisdiction: 001
Libraries:
ANC.DT.22 Asymptomatic bacteriuria (ASB) diagnosis
Actions:
ANC.DT.22 Asymptomatic bacteriuria (ASB) diagnosis:
When: named-event: ANC.B10.4 Diagnosis and treatment
Then:
A woman is considered to have ASB if she has one of the following test results: – Positive culture (> 100,000 bacteria/ml) – Gram-staining positive – Urine dipstick test positive (nitrites or leukocytes) Seven-day antibiotic regimen is recommended for all pregnant women with asymptomatic bacteriuria (ASB) to prevent persistent bacteriuria, preterm birth and low birth weight. "Midstream urine culture is the recommended method for diagnosing asymptomatic bacteriuria (ASB) in pregnancy. In settings where urine culture is not available, on-site midstream urine Gramstaining is recommended over the use of dipstick tests as the method for diagnosing ASB in pregnancy" (2)
If: applicability: (((((((((("Midstream urine culture (recommended)" = "Positive – any agent") OR ("Midstream urine culture (recommended)" = "Positive – Group B Streptococcus (GBS)")) OR ("Midstream urine Gram-staining" = "Positive")) OR ("Urine dipstick result – nitrites" = "+")) OR ("Urine dipstick result – nitrites" = "++")) OR ("Urine dipstick result – nitrites" = "+++")) OR ("Urine dipstick result – nitrites" = "++++")) OR ("Urine dipstick result – leukocytes" = "+")) OR ("Urine dipstick result – leukocytes" = "++")) OR ("Urine dipstick result – leukocytes" = "+++")) OR ("Urine dipstick result – leukocytes" = "++++") (Should Provide 7-day antibiotic regimen for asymptomatic bacteriuria (ASB))
Pregnant women with Group B Streptococcus (GBS) colonization should receive intrapartum antibiotic administration to prevent early neonatal GBS infection. "Midstream urine culture is the recommended method for diagnosing asymptomatic bacteriuria (ASB) in pregnancy. In settings where urine culture is not available, on-site midstream urine Gramstaining is recommended over the use of dipstick tests as the method for diagnosing ASB in pregnancy" (2)
If: applicability: "Midstream urine culture (recommended)" = "Positive – Group B Streptococcus (GBS)" (Should Provide intrapartum antibiotic to prevent early neonatal Group B Streptococcus (GBS) infection counselling)